Patent Assignment
Reel/Frame 020838/0701
Change of Name
Recorded: 2008-04-17
Pages: 20
Assignor
MITSUBISHI PHARMA CORPORATION
Executed: 2007-10-01
Assignee
MITSUBISHI TANABE PHARMA CORPORATION
2-10, DOSHO-MACHI 3-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, 541-8505, JAPAN
Covered Properties
(74)
Transgenic Mammals Introduced a Period 1 Promoter That Confers Rhythmical Expression
Patent:
7,659,387 →
Application:
10/130,659 →
Remedies and/or Preventives for Nervous System Disorders
Medical Composition Kit for Treating Lesioned Abnormal Tissue
Compositions controlling pH range of release and /or release rate
Application:
10/319,568 →
Publication:
US 2003/0130268
Granular Preparations for Oral Administration
Novel Amide Derivatives and Medicinal Use Thereof
Excretion Accelerator for Accumulative Chlorine Compound
Remedies and/or preventives for diabetic ischemic heart diseases
Application:
10/471,659 →
Publication:
US 2005/0124632
Crystal of 6-[4-(4-pyridylamino)phenyl]-4,5-dihydro-3(2h)-pyridazinone hydrochloride trihydrate
Application:
10/475,515 →
Publication:
US 2004/0224956
Remedies for mammary cancer
Application:
10/483,993 →
Publication:
US 2005/0037061
Cancer diagnostics
Application:
10/483,994 →
Publication:
US 2005/0032132
Medicament inhibiting sodium/calcium exchange system
Application:
10/484,463 →
Publication:
US 2004/0259861
Drugs for Ameliorating Postcibal Hyperglycemia
Preventive and/or remedial agent for disease attributable to arteriosclerotic activity
Application:
10/487,492 →
Publication:
US 2004/0198774
Drugs Comprising Combination of Antithrombotic Agent with Pyrazolone Derivative
3-Substituted-4-Pyrimidone Derivatives
3-Substituted-4-Pyrimidone Derivatives
Thrombus/thrombogenesis inhibitors
Application:
10/489,822 →
Publication:
US 2004/0242687
Method of activating protein
Application:
10/497,516 →
Publication:
US 2005/0123532
Remedy for Sleep Disturbance
Preventives and/or remedies for subjects with the expression or activation of her2 and/or egfr
Application:
10/516,360 →
Publication:
US 2005/0148607
Method of examining and diagnosing schizophrenia
Application:
10/519,792 →
Publication:
US 2005/0164400
Inhibitors for excessive accumulation of sodium ion in cells
Application:
10/525,980 →
Publication:
US 2006/0167013
Antibody Recognizing Antigen
Application:
10/530,171 →
Publication:
US 2006/0057147
Isoquinoline Compounds and Medicinal Use Thereof
3-Substituted-4-Pyrimidone Derivatives
Method for protecting thiol group of protein
Application:
10/539,756 →
Publication:
US 2006/0257393
Blood-brain barrier disruption inhibitor
Application:
10/541,702 →
Publication:
US 2006/0111418
Peptide Conjugate
Application:
10/544,628 →
Publication:
US 2007/0059376
The Enantiomer of Tenatoprazole and the Use Thereof in Therapy
Monoclonal Antibody and Gene Encoding the Same, Hybridoma, Pharmaceutical Composition, and Diagnostic Reagent
2,3,6-Trisubstituted-4-Pyrimidone Derivatives
Compounds having serotonin 5-ht17 receptor antagonist activity and muscarinic m4 receptor agonist activity and their use in the treatment of psychotic disorders
Application:
10/551,138 →
Publication:
US 2006/0199978
Specific nad(p)h oxidase inhibitor
Application:
10/552,340 →
Publication:
US 2007/0082910
Composition for oral administration containing alkylene dioxybenzene derivative
Application:
10/554,205 →
Publication:
US 2006/0252820
Corneal Perception Recovery Drug Containing Amide Compound
Liposome
Application:
10/581,169 →
Publication:
US 2007/0248541
Alpha-Amino Acid Derivatives and Use Thereof as Medicines
Method of Amplifying Hematopoietic Stem Cell and Hematopoietic Progenitor Cell
Agent for Prophylactic and/or Therapeutic Treatment of Retinopathy
Application:
10/587,860 →
Publication:
US 2008/0039380
Pharmaceutical Formulations Comprising Paraoxonase
Novel Therapeutic Agent for Amyotrophic Lateral Sclerosis (Als) or Diseases Caused by Als
Application:
10/588,778 →
Publication:
US 2008/0161378
Indazole Compound and Pharmaceutical Use Thereof
Medicament for Preventing and/or Treating Ischemic Cardiovascular Disease
Application:
10/591,602 →
Publication:
US 2007/0270409
Insulin Resistance-Improving Agent
Application:
10/594,215 →
Publication:
US 2007/0212325
Method Of Screening Molecule Associated With Psychiatric Disorder
Application:
10/596,985 →
Publication:
US 2008/0038198
Medicinal Compositions for Preventing or Treating Viral Myocarditis
Visual Function Disorder Improving Agents
Method for Treatment of Gastroesophageal Reflux Disease
Application:
11/507,010 →
Publication:
US 2006/0281781
Preventive Agent/Remedial Agent for Constipation Predominant Ibs
Schizophrenia related gene
Application:
11/518,868 →
Publication:
US 2007/0074295
Preventive and/or Therapeutic Agent for Cancer
Application:
11/547,334 →
Publication:
US 2008/0260741
2-Morpholino-4-Pyrimidone Compound
Diagnostic and/or Remedy for Ovarian Cancer
Application:
11/575,406 →
Publication:
US 2008/0069867
6- (Pyridinyl) -4-Pyrimidone Derivates as Tau Protein Kinase 1 Inhibitors
Production Method of Phenylethanolamine Compound, and Its Intermediate
Therapeutic Agent for Nonviral Hepatitis
Application:
11/587,759 →
Publication:
US 2007/0232614
Method of Assaying Substance Capable of Changing Mitochondrial Membrane Potential
Pyrazolone Compounds Useful for Treatment of Cerebrovascular Disorders Associated with Ischemic Stroke
Antibody and Utilization of the Same
Patent:
8,168,188 →
Application:
11/659,829 →
Molecular Chaperone Function Regulator
Application:
11/661,413 →
Publication:
US 2008/0200433
Morpholine Compound
Agent for prophylactic and/or therapeutic treatment of diabetes
Application:
11/665,379 →
Publication:
US 2010/0055066
Carboxylic Acid Derivative Containing Thiazole Ring and Pharmaceutical Use Thereof
Isoquinoline Compound and Pharmaceutical Use Thereof
Process for Producing Protein with Reduction of Acidic Sugar Chain and Glycoprotein Produced Thereby
Therapeutic Agent for Schizophrenia
Application:
11/767,594 →
Publication:
US 2007/0244147
Thiazolidine Derivatives and Medicinal Use Thereof
Therapeutic Agent for Attention-Deficit Hyperactivity Disorder
Application:
11/814,062 →
Publication:
US 2009/0048243
Salt of Proline Derivative, Solvate Thereof, and Production Method Thereof
Quinazoline derivatives
Application:
11/819,679 →
Publication:
US 2007/0265260
Optically Active Tetrahydronaphthalene Derivative
Application:
11/883,743 →
Publication:
US 2008/0194640
Antiviral Agent
Application:
11/885,418 →
Publication:
US 2009/0028820
Pharmaceutical Products
Application:
11/908,064 →
Publication:
US 2009/0062295
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 6, 2002
From: YUKI, SATOSHI; YOSHII, NARUHIKO
To: MITSUBISHI PHARMA CORPORATION
Reel/Frame 013266/0717 →
Assignment of Assignor's Interest
Dec 31, 2002
From: OKU, KINUKO; IWAMOTO, TAKAKO; ONO, TAKASHI
To: LEQUIO PHARMA CO., LTD.; MITSUBISHI PHARMA CORPORATION
Reel/Frame 013690/0164 →
Assignment of Assignor's Interest
Dec 31, 2002
From: OKU, KINUKO; IWAMOTO, TAKAKO; ONO, TAKASHI
To: LEQUIO PHARMA CO., LTD.; MITSUBISHI PHARMA CORPORATION
Reel/Frame 014191/0252 →
Assignment of Assignor's Interest
Jan 28, 2003
From: SAGARA, KAZUYOSHI; OMURA, TOMOYUKI; SAMEMOTO, HIROFUMI; KOMATSU, HIROTSUGU
To: MITSUBISHI PHARMA CORPORATION
Reel/Frame 013698/0682 →
Assignment of Assignor's Interest
May 8, 2003
From: NAKAMURA, MITSUHARU; KAMAHORI, TAKAO; ISHIBUCHI, SEIGO; NAKA, YOICHI
To: MITSUBISHI PHARMA CORPORATION
Reel/Frame 014040/0708 →
Assignment of Assignor's Interest
Jul 21, 2003
From: NOMURA, TATSUO
To: MITSUBISHI PHARMA CORPORATION
Reel/Frame 014300/0858 →
Assignment of Assignor's Interest
Aug 27, 2003
From: TEI, HAJIME; SAKAKI, YOSHIYUKI; TAKAHASHI, RI-ICHI
To: MITSUBISHI PHARMA CORPORATION
Reel/Frame 014434/0741 →
Assignment of Assignor's Interest
Aug 27, 2003
From: YAMAZAKI, SHIN; MENAKER, MICHAEL; ABE, MICHIKAZU
To: VIRGINIA, UNIVERSITY OF
Reel/Frame 014432/0870 →
Assignment of Assignor's Interest
Oct 17, 2003
From: SUZUKI, KAZUO; NAKAJIMA, SHIGEKAZU; YANO, SHINJI
To: MITSUBISHI PHARMA CORPORATION
Reel/Frame 014602/0544 →
Assignment of Assignor's Interest
Feb 23, 2004
From: ISHII, SHINICHI; SASAKI, KAZUYO; UENO, HIROAKI
To: MITSUBISHI PHARMA CORPORATION
Reel/Frame 015471/0525 →
Assignment of Assignor's Interest
Mar 4, 2004
From: OBA, KENZO
To: MITSUBISHI PHARMA CORPORATION
Reel/Frame 015039/0406 →
Assignment of Assignor's Interest
Mar 17, 2004
From: KOBAYASHI, YOSHIKAZU; AZUMA, HIROSHI; MOURI, YUKO
To: MITSUBISHI PHARMA CORPORATION
Reel/Frame 015639/0028 →
Assignment of Assignor's Interest
Apr 22, 2004
From: HOSOKAWA, SAIKO; NIKI, HISAE
To: MITSUBISHI PHARMA CORPORATION
Reel/Frame 015249/0224 →
Assignment of Assignor's Interest
Jun 22, 2004
From: ASATANI, HARUKI; TSUBOI, AKIO; ZHANG, SUOJIANG; OHURA, SHINJI
To: MITSUBISHI PHARMA CORPORATION
Reel/Frame 015491/0390 →
Assignment of Assignor's Interest
Jul 14, 2004
From: SATOH, NAOYA
To: MITSUBISHI PHARMA CORPORATION
Reel/Frame 015561/0583 →
Assignment of Assignor's Interest
Aug 4, 2004
From: NIKI, HISAE; TAGAWA, TOSHIAKI; HOSOKAWA, SAIKO
To: MITSUBISHI PHARMA CORPORATION
Reel/Frame 015649/0041 →
Assignment of Assignor's Interest
Sep 21, 2004
From: UEHARA, FUMIAKI; ARITOMO, KEIICHI; SHODA, AYA; HIKI, SHINSUKE
To: MITSUBISHI PHARMA CORPORATION; SANOFI-SYNTHELABO
Reel/Frame 015805/0811 →
Assignment of Assignor's Interest
Oct 11, 2004
From: YAMADA, KEIICHI; KURITA, KATSUMI; TANAKA, TADASHI; TANAKA, MASAHIKO
To: MITSUBISHI PHARMA CORPORATION
Reel/Frame 015241/0286 →
Assignment of Assignor's Interest
Oct 19, 2004
From: KITADA, YOSHIMI; SATOH, NAOYA
To: MITSUBISHI PHARMA CORPORATION
Reel/Frame 015902/0367 →
Assignment of Assignor's Interest
Oct 25, 2004
From: TESHIMA, KOJI; MINOGUCHI, MASANORI
To: MITSUBISHI PHARMA CORPORATION
Reel/Frame 015938/0836 →
Assignment of Assignor's Interest
Jan 5, 2005
From: KOUNO, TAKAHARU; KATSUMURA, YASUHIKO
To: MITSUBISHI PHARMA CORPORATION
Reel/Frame 016125/0634 →
Assignment of Assignor's Interest
Feb 8, 2005
From: UEHARA, FUMIAKI; ARITOMO, KEIICHI; SHODA, AYA; HIKI, SHINSUKE
To: MITSUBISHI PHARMA CORPORATION; SANOFI-SYNTHELABO
Reel/Frame 016239/0603 →
Change of Name
Jul 22, 2005
From: SANOFI-SYNTHELABO
To: SANOFI-AVENTIS
Reel/Frame 016345/0189 →
Assignment of Assignor's Interest
Nov 23, 2005
From: UNIVERSITY OF VIRGINIA
To: UNIVERSITY OF VIRGINIA PATENT FOUNDATION
Reel/Frame 017272/0782 →
Change of Address
Dec 17, 2010
From: MITSUBISHI TANABE PHARMA CORPORATION
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 025523/0517 →